144 related articles for article (PubMed ID: 34313449)
1. Prediction of the Synergistic Glass Transition Temperature of Coamorphous Molecular Glasses Using Activity Coefficient Models.
Zhao X; Cheng S; Koh YP; Kelly BD; McKenna GB; Simon SL
Mol Pharm; 2021 Sep; 18(9):3439-3451. PubMed ID: 34313449
[TBL] [Abstract][Full Text] [Related]
2. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.
Löbmann K; Laitinen R; Grohganz H; Gordon KC; Strachan C; Rades T
Mol Pharm; 2011 Oct; 8(5):1919-28. PubMed ID: 21815614
[TBL] [Abstract][Full Text] [Related]
3. Design of a Stable Coamorphous System Using Lactose as an Antiplasticizing Agent for Diphenhydramine Hydrochloride with a Low Glass Transition Temperature.
Ueda H; Hirakawa Y; Miyano T; Imono M; Tse JY; Uchiyama H; Tozuka Y; Kadota K
Mol Pharm; 2022 Apr; 19(4):1209-1218. PubMed ID: 35316068
[TBL] [Abstract][Full Text] [Related]
4. Determination of the Optimal Molar Ratio in Amino Acid-Based Coamorphous Systems.
Liu J; Rades T; Grohganz H
Mol Pharm; 2020 Apr; 17(4):1335-1342. PubMed ID: 32119557
[TBL] [Abstract][Full Text] [Related]
5. The Role of Glass Transition Temperatures in Coamorphous Drug-Amino Acid Formulations.
Kissi EO; Kasten G; Löbmann K; Rades T; Grohganz H
Mol Pharm; 2018 Sep; 15(9):4247-4256. PubMed ID: 30020794
[TBL] [Abstract][Full Text] [Related]
6. Improving the Solubility, Dissolution, and Bioavailability of Ibrutinib by Preparing It in a Coamorphous State With Saccharin.
Shi X; Song S; Ding Z; Fan B; Huang W; Xu T
J Pharm Sci; 2019 Sep; 108(9):3020-3028. PubMed ID: 31067482
[TBL] [Abstract][Full Text] [Related]
7. Preparation and Characterization of a Rifampicin Coamorphous Material with Tromethamine Coformer: An Experimental-Theoretical Study.
Queiroz LHS; Barros RS; de Sousa FF; Lage MR; Sarraguça MC; Ribeiro PRS
Mol Pharm; 2024 Mar; 21(3):1272-1284. PubMed ID: 38361428
[TBL] [Abstract][Full Text] [Related]
8. Theoretical Model for the Structural Relaxation Time in Coamorphous Drugs.
Phan AD; Knapik-Kowalczuk J; Paluch M; Hoang TX; Wakabayashi K
Mol Pharm; 2019 Jul; 16(7):2992-2998. PubMed ID: 31095393
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Physical Stability and Synchronized Release of Febuxostat and Indomethacin in Coamorphous Solids.
Moinuddin SM; Shi Q; Tao J; Guo M; Zhang J; Xue Q; Ruan S; Cai T
AAPS PharmSciTech; 2020 Jan; 21(2):41. PubMed ID: 31898765
[TBL] [Abstract][Full Text] [Related]
10. Glass Transition Dynamics and Physical Stability of Amorphous Griseofulvin in Binary Mixtures with Low-
Tu W; Knapik-Kowalczuk J; Chmiel K; Paluch M
Mol Pharm; 2019 Aug; 16(8):3626-3635. PubMed ID: 31287704
[TBL] [Abstract][Full Text] [Related]
11. Coamorphous Active Pharmaceutical Ingredient-Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability.
Newman A; Reutzel-Edens SM; Zografi G
J Pharm Sci; 2018 Jan; 107(1):5-17. PubMed ID: 28989014
[TBL] [Abstract][Full Text] [Related]
12. Crystallization kinetics and molecular dynamics of binary coamorphous systems of nimesulide and profen analogs.
Zhang J; Shi Q; Qu T; Zhou D; Cai T
Int J Pharm; 2021 Dec; 610():121235. PubMed ID: 34743960
[TBL] [Abstract][Full Text] [Related]
13. Triple Strategies to Improve Oral Bioavailability by Fabricating Coamorphous Forms of Ursolic Acid with Piperine: Enhancing Water-Solubility, Permeability, and Inhibiting Cytochrome P450 Isozymes.
Yu D; Kan Z; Shan F; Zang J; Zhou J
Mol Pharm; 2020 Dec; 17(12):4443-4462. PubMed ID: 32926628
[TBL] [Abstract][Full Text] [Related]
14. Eutectic Mixture Formation and Relaxation Dynamics of Coamorphous Mixtures of Two Benzodiazepine Drugs.
Valenti S; Cazorla C; Romanini M; Tamarit JL; Macovez R
Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678825
[TBL] [Abstract][Full Text] [Related]
15. Molecular Dynamics and Physical Stability of Coamorphous Ezetimib and Indapamide Mixtures.
Knapik J; Wojnarowska Z; Grzybowska K; Jurkiewicz K; Tajber L; Paluch M
Mol Pharm; 2015 Oct; 12(10):3610-9. PubMed ID: 26301858
[TBL] [Abstract][Full Text] [Related]
16. Solvent influence on the phase behavior and glass transition of Amorphous Solid Dispersions.
Dohrn S; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
Eur J Pharm Biopharm; 2021 Jan; 158():132-142. PubMed ID: 33212185
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic insights into the crystallization of coamorphous drug systems.
Heng W; Song Y; Luo M; Hu E; Wei Y; Gao Y; Pang Z; Zhang J; Qian S
J Control Release; 2023 Feb; 354():489-502. PubMed ID: 36646287
[TBL] [Abstract][Full Text] [Related]
18. Effect of Spray Drying on Amorphization of Indomethacin Nicotinamide Cocrystals; Optimization, Characterization, and Stability Study.
Tawfeek HM; Chavan T; Kunda NK
AAPS PharmSciTech; 2020 Jun; 21(5):181. PubMed ID: 32607628
[TBL] [Abstract][Full Text] [Related]
19. Systematic Investigation on the Glass Transition Temperature of Binary and Ternary Sugar Mixtures and the Applicability of Gordon-Taylor and Couchman-Karasz Equation.
Schugmann M; Foerst P
Foods; 2022 Jun; 11(12):. PubMed ID: 35741877
[TBL] [Abstract][Full Text] [Related]
20. Physicochemical evaluation of PVP-thiazide diuretic interactions in co-spray-dried composites--analysis of glass transition composition relationships.
Tajber L; Corrigan OI; Healy AM
Eur J Pharm Sci; 2005 Apr; 24(5):553-63. PubMed ID: 15784345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
